한글목차

디지털 치료제 세계 시장은 2030년까지 329억 달러에 이를 전망

2023년에 57억 달러로 추정되는 디지털 치료제 세계 시장은 분석 기간인 2023-2030년에 CAGR 28.6%로 성장하여 2030년에는 329억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 치료/케어 용도는 CAGR 29.1%를 나타내고, 분석 기간 종료시에는 281억 달러에 이를 것으로 예측됩니다. 예방 용도 분야의 성장률은 분석 기간중 CAGR 26.0%로 추정됩니다.

미국 시장은 23억 달러로 추정, 중국은 CAGR 32.2%로 성장 예측

미국의 디지털 치료제 시장은 2023년에 23억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 32억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2023-2030년간 CAGR은 32.2%입니다. 기타 주목해야 할 지역별 시장으로서는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 25.4%와 23.6%를 나타낼 것으로 예측됩니다. 유럽에서는 독일이 CAGR 28.5%를 나타낼 전망입니다.

세계 디지털 치료제 시장 - 주요 동향 및 촉진요인 요약

디지털 치료제(DTx)는 의료 산업의 혁신적인 분야로, 질병을 예방, 관리 및 치료하기 위한 소프트웨어 프로그램을 통해 증거에 기반한 치료 중재를 제공하는 데 초점을 맞추었습니다. 이러한 치료 중재는 종종 모바일 앱, 디지털 기기, 온라인 플랫폼을 통해 제공되며, 기존 치료와 병행하거나 단독으로 사용할 수 있도록 설계되어 있습니다. 디지털 치료는 행동과학, 인공지능, 데이터 분석을 활용하여 개인화된 치료 계획을 제공하고, 환자의 진행 상황을 실시간으로 모니터링하며, 건강 상태를 개선하기 위한 피드백을 제공합니다. 임상 검증은 디지털 치료의 근간으로, 이러한 솔루션이 기존 의약품에 필적하는 엄격한 유효성 및 안전성 기준을 충족하는지 확인합니다.

디지털 치료는 당뇨병, 고혈압과 같은 만성질환, 불안, 우울증과 같은 정신질환 등 다양한 질환에 적용되고 있습니다. DTx 솔루션은 디지털 도구를 기존 의료 서비스에 통합함으로써 만성 질환을 효과적으로 관리하는 데 필수적인 지속적인 모니터링과 실시간 개입을 제공할 수 있습니다. 또한, 이러한 솔루션은 환자가 자신의 건강을 더 잘 통제할 수 있도록 함으로써 환자 참여를 높이고 치료 계획의 순응도를 향상시킬 수 있습니다. 또한, 디지털 치료는 의료 서비스 접근성의 격차를 해소하고, 확장 가능하고 비용 효율적이며 쉽게 접근할 수 있는 디지털 플랫폼을 통해 의료 서비스를 제대로 받지 못하는 사람들에게 지원을 제공할 수 있습니다. 게임화 및 사용자 친화적인 인터페이스를 도입함으로써 환자의 참여와 순응도를 더욱 향상시키고, 개인이 치료 계획을 더 쉽게 준수할 수 있도록 돕습니다.

디지털 치료 시장의 성장은 여러 가지 요인에 의해 주도되고 있습니다. 디지털 치료는 환자 결과를 크게 개선할 수 있는 맞춤형 중재를 제공하기 때문에 만성 질환의 유병률 증가와 개인 맞춤형 의료에 대한 수요 증가가 주요 동인으로 작용하고 있으며, AI, 머신러닝, 모바일 헬스 기술의 기술 발전으로 DTx 솔루션의 역량과 도달 범위가 더욱 효과적이고 사용자 친화적으로 개선되고 있습니다. DTx 솔루션의 역량과 도달 범위를 강화하여 더욱 효과적이고 사용자 친화적으로 만들고 있습니다. 소비자 행동도 중요한 촉진요인으로, 환자들은 디지털 헬스 툴을 더욱 편안하게 사용하고 적극적인 건강 관리를 추구하고 있습니다. 규제 당국의 지원과 의료 서비스 제공업체와 보험사의 디지털 치료법에 대한 인식은 DTx 솔루션의 효과와 신뢰성을 입증하며 시장을 더욱 촉진하고 있습니다. 또한, 코로나19 사태는 디지털 헬스 기술 채택을 가속화하여 원격 의료 솔루션의 중요성을 강조하고 디지털 치료 분야에 대한 투자를 늘리고 있습니다. 이러한 요인들이 종합적으로 작용하여 헬스케어 분야에서 디지털 치료의 견조한 성장과 채택 확대에 기여하고 있습니다.

조사 대상 기업 예(총 136건)

• Aptar Digital Health
• Better Therapeutics, Inc
• Biofourmis Inc.
• Canary Health, Inc.
• Click Therapeutics, Inc.
• Fitbit Health Solutions
• Pear Therapeutics, Inc.
• Wellthy Therapeutics Pvt Ltd

목차

제1장 조사 방법

제2장 주요 요약

• 시장 개요
• 주요 기업
• 시장 동향과 촉진요인
• 세계 시장 전망

제3장 시장 분석

• 미국
• 캐나다
• 일본
• 중국
• 유럽
• 프랑스
• 독일
• 이탈리아
• 영국
• 기타 유럽
• 아시아태평양
• 세계 기타 지역

제4장 경쟁

영문목차

Global Digital Therapeutics Market to Reach US$32.9 Billion by 2030

The global market for Digital Therapeutics estimated at US$5.7 Billion in the year 2023, is expected to reach US$32.9 Billion by 2030, growing at a CAGR of 28.6% over the analysis period 2023-2030. Treatment / Care Application, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$28.1 Billion by the end of the analysis period. Growth in the Preventive Application segment is estimated at 26.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 32.2% CAGR

The Digital Therapeutics market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 32.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.4% and 23.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 28.5% CAGR.

Global Digital Therapeutics Market - Key Trends & Drivers Summarized

Digital Therapeutics (DTx) represents a transformative segment of the healthcare industry, focusing on delivering evidence-based therapeutic interventions through software programs to prevent, manage, or treat medical conditions. These interventions are often delivered via mobile apps, digital devices, and online platforms, and are designed to be used independently or alongside traditional medical treatments. Digital therapeutics leverage behavioral science, artificial intelligence, and data analytics to provide personalized treatment plans, monitor patient progress in real-time, and offer feedback to improve health outcomes. Clinical validation is a cornerstone of digital therapeutics, ensuring that these solutions meet rigorous standards of efficacy and safety comparable to traditional pharmaceuticals.

Digital therapeutics address a wide range of conditions, including chronic diseases like diabetes, hypertension, and mental health disorders such as anxiety and depression. By integrating digital tools with traditional healthcare, DTx solutions can offer continuous monitoring and real-time interventions, which are crucial for managing chronic diseases effectively. These solutions also empower patients by giving them greater control over their health, enhancing engagement and adherence to treatment plans. Additionally, digital therapeutics can bridge gaps in healthcare access, providing support to underserved populations through scalable, cost-effective, and easily accessible digital platforms. The incorporation of gamification and user-friendly interfaces further enhances patient engagement and compliance, making it easier for individuals to stick to their therapeutic regimens.

The growth in the digital therapeutics market is driven by several factors. The increasing prevalence of chronic diseases and the rising demand for personalized medicine are primary drivers, as digital therapeutics offer tailored interventions that can significantly improve patient outcomes. Technological advancements in AI, machine learning, and mobile health technologies are enhancing the capabilities and reach of DTx solutions, making them more effective and user-friendly. Consumer behavior is also a significant driver, with patients becoming more comfortable using digital health tools and seeking proactive management of their health. Regulatory support and the recognition of digital therapeutics by healthcare providers and insurers are further propelling the market, as these endorsements validate the efficacy and reliability of DTx solutions. Additionally, the COVID-19 pandemic has accelerated the adoption of digital health technologies, highlighting the importance of remote healthcare solutions and increasing investment in the digital therapeutics sector. These factors collectively contribute to the robust growth and expanding adoption of digital therapeutics in the healthcare landscape.

Select Competitors (Total 136 Featured) -

• Aptar Digital Health
• Better Therapeutics, Inc
• Biofourmis Inc.
• Canary Health, Inc.
• Click Therapeutics, Inc.
• Fitbit Health Solutions
• Pear Therapeutics, Inc.
• Wellthy Therapeutics Pvt Ltd

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Digital Therapeutics is Poised to Benefit from the Increasingly Robust Outlook for Digital Health
  • Digital Healthcare Sets the Stage for the Rise of Digital Therapeutics: Global Market for Digital Health (In US$ Billion) for Years 2023, 2025, and 2027
  • Global Economic Update
  • Competition
  • Digital Therapeutics - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • Digital Therapeutics: Overview & Market Outlook
  • Recent Market Activity
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Global Focus on Meeting Unmet Needs in Mental Healthcare to Benefit Growth of Digital Therapeutics
  • Shockingly High Burden of Mental Disorders & the Ensuing Focus to Meet Unmet Care Needs Primes Digital Therapeutics for Mass Adoption: Global Economic Cost of Mental Illnesses (In US$ Trillion) for Years 2023, 2025, 2027, 2029 & 2031
  • Artificial Intelligence to Play a Key Role in Improving the Effectiveness of Digital Therapeutics
  • High Prevalence of Chronic Diseases and Growing Focus Long-Term Management & Preventative Healthcare Widens Growth Opportunities
  • Rising Prevalence of Chronic Diseases Amplifies the Need for Addressing Management of These Diseases Through Digital Therapeutics: Global Cost of Chronic Diseases (In US$ Trillion) for the Years 2023, 2025, 2027, 2029 and 2031
  • Here's How Digital Therapeutics Can Help Improve Clinical Outcomes Across the Cardiac Continuum
  • Global Annual Medical Cost of Cardiovascular Diseases in US$ Billion (2010-2030)
  • How Digital Therapeutics is Changing the Oncology Care Landscape?
  • Worrisome Epidemic Increase in Cancer Incidence to Help Accelerate Adoption of Digital Therapeutics: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • Rise of mHealth & Smart Medical Devices & Wearables Paves the Way for More Spontaneous Adoption of Digital Therapeutics
  • Growing Familiarity with mHealth & Use of Medical Wearables Means There is One Less Obstacle in the Implementation of Digital Therapeutics: Global Market for mHealth & Medical Wearables (In US$ Billion) for Years 2023, 2025, 2027, 2029 and 2031
  • As Healthcare Costs Continue to Spiral, Growing Much Faster Than National GDP, Focus Shifts to Digital Therapeutics for its Ability to Lower Cost of Care
  • Growing Urgency to Rein-in Spiraling Healthcare Costs Leads Healthcare Community to Take a Closer Look at Digital Therapeutics: Healthcare Costs as a % of GDP by Country 2020 VS 2023
  • Growing Preference for Personalized Medicine Doubles the Focus on Digital Therapeutics
  • Robust Outlook for Personalized Medicine to Create a Parallel Opportunity for Digital Therapeutics: Global Market for Personalized Medicines (In US$ Billion) for Years 2023 2025, 2027, 2029 and 2031
  • Here's How AR/VR Technologies are Changing the Future of Digital Therapeutics
  • The Many Benefits of 5G in Healthcare to Catalyze Adoption of Digital Therapeutics
  • Rapid Penetration of 5G Will Make Implementation of Digital Therapeutics Seamless & More Efficient to Use: Global 5G Subscription (In Million) for Years 2023, 2025, 2027 and 2029
  • Technology and Innovation to Continue to Drive Adoption of Digital Therapeutics
  • Cybersecurity Storms Into the Spotlight. Here's Why
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Digital Therapeutics Market Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 3: World 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for B2B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 5: World 7-Year Perspective for B2B by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 6: World Recent Past, Current & Future Analysis for B2C by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 7: World 7-Year Perspective for B2C by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Treatment / Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 9: World 7-Year Perspective for Treatment / Care by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Preventive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 11: World 7-Year Perspective for Preventive by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 12: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 13: USA 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 14: USA Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 15: USA 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• CANADA
  • TABLE 16: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 17: Canada 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 18: Canada Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 19: Canada 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• JAPAN
  • TABLE 20: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 21: Japan 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 22: Japan Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 23: Japan 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• CHINA
  • TABLE 24: China Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 25: China 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 26: China Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 27: China 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• EUROPE
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 28: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Thousand for Years 2023 through 2030 and % CAGR
  • TABLE 29: Europe 7-Year Perspective for Digital Therapeutics by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
  • TABLE 30: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 31: Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 32: Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 33: Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• FRANCE
  • TABLE 34: France Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 35: France 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 36: France Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 37: France 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• GERMANY
  • TABLE 38: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Germany 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 40: Germany Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 41: Germany 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• ITALY
  • TABLE 42: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 43: Italy 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 44: Italy Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Italy 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• UNITED KINGDOM
  • TABLE 46: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 47: UK 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 48: UK Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 49: UK 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• REST OF EUROPE
  • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 51: Rest of Europe 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 52: Rest of Europe Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 53: Rest of Europe 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• ASIA-PACIFIC
  • Digital Therapeutics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 54: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 55: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 57: Asia-Pacific 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030
• REST OF WORLD
  • TABLE 58: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Sales Channel - B2B and B2C - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 59: Rest of World 7-Year Perspective for Digital Therapeutics by Sales Channel - Percentage Breakdown of Value Revenues for B2B and B2C for the Years 2024 & 2030
  • TABLE 60: Rest of World Recent Past, Current & Future Analysis for Digital Therapeutics by Application - Treatment / Care and Preventive - Independent Analysis of Annual Revenues in US$ Thousand for the Years 2023 through 2030 and % CAGR
  • TABLE 61: Rest of World 7-Year Perspective for Digital Therapeutics by Application - Percentage Breakdown of Value Revenues for Treatment / Care and Preventive for the Years 2024 & 2030

IV. COMPETITION